Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Nichi-Iko

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Nichi-Iko's Japan sales performance.

Cortellis Drugs to Watch in 2020 report

Cortellis Drugs to Watch in 2020 report patients. The drug is under regulatory review in Japan, where a filing was submitted in July 2019. ... Sales are projected at $1.589bn in 2024. 5. Filgotinib from Gilead/Galapagos is an oral JAK1 inhibitor in regulatory review in the US, EU and Japan for

Pharma funding and M&A in 2020

Pharma funding and M&A in 2020 All this in the same year that Japan’s Takeda acquired Shire, making the combined entity one of the top ten pharmaceutical firms by revenue (and only the second non- American

AZ’s Imfinzi gets US OK in small cell lung cancer, challenging Tecentriq

AZ’s Imfinzi gets US OK in small cell lung cancer, challenging Tecentriq A decision on first-line ES-SCLC is due in Europe and Japan before year-end, and the drug has already been approved for this indication in Singapore.

Merck gets first approval for MET inhibitor tepotinib in Japan

Merck gets first approval for MET inhibitor tepotinib in Japan First worldwide approval for MET inhibitor. Japan’s medicines regulator has approved Merck KGaA’s oral MET inhibitor tepotinib for non-small cell lung cancer with MET exon 14 (METex14) mutations, ... The study included 99 patients – 15 from Japan

FDA says no to Lilly, Boehringer’s Jardiance in type 1 diabetes

FDA says no to Lilly, Boehringer’s Jardiance in type 1 diabetes Last July the FDA also turned down AstraZeneca’s filing for Farxiga in type 1 diabetes, although the drug has been approved in this indication in Europe and Japan.

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Onyx Health Ltd

Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national...

Latest intelligence

The other side of … rheumatoid arthritis
For Georgie, patient activation fuelled her motivation to find life without pain. So when blood tests came back normal, she felt confident to pursue referral until RA was confirmed......
How to lessen site burden with a targeted patient recruitment strategy
Picture this: you’ve created your patient recruitment strategy and you find more and more patients are undertaking the pre-screening, you probably think – success! But then you find out, getting...
Peter Howarth
Exploring the potential of eosinophils
GSK’s Peter Howarth talks about the emerging research that suggests there is a varied role for eosinophils...

Infographics